abstract Gene products such as organelles, proteins and RNAs are actively transported to synaptic terminals for the remodeling of pre-existing neuronal connections and formation of new ones. Proteins described as molecular motors mediate this transport and utilize specialized cytoskeletal proteins that function as molecular tracks for the motor based transport of cargos. Molecular motors such as kinesins and dynein's move along microtubule tracks formed by tubulins whereas myosin motors utilize tracks formed by actin. Deficits in active transport of gene products have been implicated in a number of neurological disorders. We describe such disorders collectively as "transportopathies". Here we review current knowledge of critical components of active transport and their relevance to neurodegenerative diseases.
actively transported to synaptic terminals [1] .
Most of the proteins necessary for the axon and synaptic terminals must be synthesized in the cell body and then transported down the axon [1] . An active transport mechanism is necessary not only to supply newly synthesized materials from soma; but also to transport of damaged organelles from the axon terminal to the cell body [2] [3] [4] . 
Molecular motors in neuronal tracks
Microtubules (MT) are key determinants of neuronal polarity [10] [11] [12] [13] and form the transport highways for cargo trafficking in axons and dendrites in neurons [6] . MT are formed from the association of dimers of α-tubulin and β-tubulin into protofilaments. The head to tail association of α-β heterodimers imparts polarity, β monomer pointing towards the plus end (faster growing end), α monomers are pointing towards minus (or slow growing end).
Protein such as g tubulin binds to the minus ends [14] whereas end binding proteins (EB) bind to the plus end of MT [15, 16] A. Kinesinand dynein-driven transports on microtubules Active transport of gene products is mediated by three classes of molecular motor proteins: kinesin, dynein and myosin. Anterograde axonal transport (from cell body to synaptic terminals) of cargos is mediated by kinesin proteins, whereas retrograde transport (from synaptic terminals to cell body) use the dyneindynactin system. Both kinesins and dyneins move along microtubules and require ATP for motility [22] . Kinesins were originally identified by Brady [23] and Vale et al., [24] , and were found to be composed of two heavy chains (KHC) and two light chains (KLC). To date, more than 45 kinesins, which are classified into 14 classes, have been identified in mammals [1, 25, 26] . Kinesins mediate a number of important processes such as cell division, differentiation and development of the nervous system by transporting different gene products such as proteins, organelles and RNA (reviewed in [1, [27] [28] [29] [30] [31] [32] ). Kinesin heavy chain, ApKHC1 and light chain ApKLC2 are upregulated during the formation of long-term memory in marine snail Aplysia. The coordinated regulation of axonal transport in pre and post-synaptic neurons has been identified to play a critical mediator of long-term learning-related plasticity [33] .
Dynein protein was originally identified from cilia by Gibbons and Rowe [34] and from the nervous system by Burns and Pollard [35] . [22, 29, 30, 36, 37] ).
Dynein requires dynactin, which increases the motor efficiency of dynein and cross-links dynein for retrograde transport [38, 39] . Like kinesins, dyneins are also involved in a number of functions such as cell division, retrograde transport of organelles and vesicles, and are important in the development of the nervous system (reviewed in [22, 28, 36, 40, 41] Actin cytoskeleton is also highly responsive to changes in electrical activity, which can be dynamically rearranged by depolarization [80] .
In addition, actin polymerization is required for the maintenance of prolonged periods of synaptic activity during LTP [81] . Rho family proteins of GTPases have been shown to act as molecular switches that increase/decrease actin polymerization rates, crosslinking activities, or branch formation [82] , which could be a cellular basis for impaired cognitive functions. 
neuronal cargos

Pathologies of axonal transport in neurodegenerative diseases -"transportopathies"
As illustrated above, molecular motors regulate several vital processes in neurons. Disruption of axonal transport is a hallmark and precipitating factor of a wide variety of neurodegenerative diseases. Table 1 Here we discuss three different causes of axonal transport defects: gene mutation, oxidative stress and post-translational modifications of the transport machinery.
We specifically focus on Alzheimer's disease (AD), frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) and briefly describe transport defects in other nervous system diseases with axonal pathologies.
3a. Gene mutations and axonal transport defects
Mutations in motor proteins and other defects in intracellular transport have been described to cause neuropathologies [111] . [176, 189] PS1 Mutations increase KLC phosphorylation and cargo release [190] Mitochondrial abnormalities lead to reduction in the number of microtubules [136] Huntington's disease (HD) Mutant Htt causes defective anterograde mitochondrial movement [259] Amyotrophic lateral sclerosis (ALS) Kinesin-associated protein 3 (KAP3) is sequestrated by misfolded SOD1 and results in axonal transport inhibition of ChAT [210] Dynactin mutation in the p150 subunit [154, [216] [217] [218] [219] Mutations in dynein-dynactin retrograde system protein genes [222] [223] [224] KHC gene mutation [262] Mislocalization and disruption of dynein function [214] Frontotemporal dementia (FTD) Hyperphosphorylated tau deposition decrease binding of motor proteins to MT tracks [167, 168, 176] Mutation of FUS, which is a DNA/RNA-binding protein involved in transport of mRNA molecules [263] Hereditary spastic paraplegias (HSP) Mutations in the KIF5A in families with SPG10 reduce microtubule binding affinity [240] SPG7 models exhibit impaired mitochondrial axonal transport [241] HSAN II FAM134B mutations lead to KIF1A mutations [123] Charcot-Marie-Tooth (CMT2) DYNC1H1 mutation impairs dynein heavy chain 1 involved retrograde axonal transport [264] Mfn2 mutation produces a severe mitochondrial transport disorder [257] Mutation in kinesin 5A [249] KIF1Bβ mutation [130] axonal CMT Expression of mutant HSPB1 decreased acetylated α-tubulin abundance and induced axonal transport deficits [251] Mutations in GDAP1 alter the interaction between mitochondria and the microtubule cytoskeleton and affect mitochondrial axonal transport [252, 253, 255] X-linked spinal and bulbar muscular atrophy (SBMA)
Androgen receptor gene mutations with enlargement of the CAG repeat form aggregates that alter axonal trafficking [265] [266] [267] Parkinson's disease (PD) Mutation and phosphorylation of α-synuclein reduces its axonal transport [268] Mutations of parkin, PINK1, and DJ-1 lead to damage to mitochondria and perturb transport of mitochondria through axons [269, 270] Inhibition of complex I of the electron transport chain decreases anterograde and increases retrograde axonal transport of membranous vesicles [271] Multiple sclerosis (MS) Ca
2+
, free radical production and mitochondrial dysfunction impair axonal transport [272] Spinal muscular atrophy (SMA) SMN1 mutation leads to reduced transport of specific mRNAs within motor neurons [273, 274] polyglutamine disorder (polyQ) Polyglutamine proteins interrupt axonal transport and affect enzymatic activities involved in FAT regulation [275] [276] [277] Prion diseases Intracerebral prion lead to axonal transport impairments which involves Rab7-mediated cargo attachment to the dynein-dynactin pathway [278] Glaucoma Mitochondrial dysfunction and axonal transport failure induce retinal ganglion cell death [279] Spinocerebellar ataxia type 5 (SCA5) SCA5 mutant spectrin impair axonal transport and induce neurodegeneration [280] Traumatic brain injury (TBI) Extensive axonal injury result in the interruption of axonal transport and long-term accumulation of proteins [281] Dystonia musculorum (dt) Microtubule network perturbation lead to axonal transport defects [282] Tuberous sclerosis (TSC1) disease kinesin-related gene ATSV is characterized as candidate genes for TSC1 disease locus on chromosome 9q34 [283] Translational Neuroscience which would result in diminished vesicular transport and mitochondrial turnover [136] .
Reduction of mitochondrial superoxide significantly prevented the deficits in axonal transport rates in Tg2576 mice, indicating that ROS of mitochondrial origin are a key factor in transducing the impact of Aβ on neuronal physiology in AD mice model [137] .
Axonal transport deficits and accumulation of depolarized mitochondria could be concurrent with axonal neuropathy and without increased reactive oxygen species production [138] .
Mitochondrial dysfunction, such as altered Ca 2+ homeostasis and increase in reactive oxygen species [139] , have been reported in both in vitro and in vivo models of ALS [140] .
Mitochondria accumulation was also shown in the axons of spinal motor neurons in sporadic ALS (SALS) patients, suggesting the deficit in mitochondria metabolism due to impaired axonal transport in ALS [141, 142] .
The autophagosomes are membraneous cargos that move bidirectionally along microtubules and are transported by kinesin and dynein/dynactin complex, which accumulate in motor neurons with altered axonal transport [143] [144] .
The dysfunction of autophagy-lysosome pathway that is responsible for recycling of intracellular contents, have been described to cause neurodegeneration [145, 146] .
Abnormal intraneuronal accumulation of autophagosomes occurs in AD [147,148],
Parkinson's disease (PD) [149] , HD [150, 151] , and in ALS patients [152] as well as the mutant dynein model (Loa mouse) [153] and the mutant dynactin-1 mouse model [154] .
3c. Post translational changes of the transport machinery by locally modulating motor function [176] .
3C1. Alzheimer's disease (AD)
Widespread
Tau, axonal transport and AD
On the other hand, kinesin-1 deficient mice (KLC1 -/-) revealed that axonal transport defects could initiate biochemical changes that induce activation of axonal c-jun N-terminal stress kinase pathways leading to abnormal tau hyperphosphorylation [177] .
Several studies have suggested a critical role for tau in axonal transport and in AD [160, [178] [179] [180] . In drosophila and mouse models of tauopathies reductions in axonal transport can exacerbate human tau protein hyperphosphorylation, formation of insoluble aggregates and tau-dependent neurodegeneration [181] . However, Yuan et al.
showed that global axonal transport rates of slow and fast transport cargoes in axons are not significantly impaired when tau expression is eliminated or increased, which suggest that tau is not essential for axonal transport [182] .
Although tau did not affect axonal transport under baseline untreated conditions, partial tau reduction can prevent Aβ-induced axonal transport defects in hAPP mice [160] . Thus, whether and how tau affects axonal transport and its physiological functions are still poorly understood. 
Aβ, axonal transport and AD
Other factors involved in transport defects observed in AD
Mutations in presenilin 1 (PS1), which is associated with early-onset familial Alzheimer's disease (FAD), have been implicated to be involved in kinesin-based axonal transport due to an interaction with glycogen synthase kinase 3β (GSK3β). The relative levels of GSK3β activity were increased either in the presence of mutant PS1 or in the absence of PS1, leading to increased kinesin light chain phosphorylation, the release of kinesin-1 from membrane-bound organelles (MBO) and reduced fast anterograde axonal transport [190] . It is also reported that defects in anterograde fast axonal transport and motor neuron deficits underlie PS-1-mediated neurodegeneration in transgenic mice expressing familial AD linked mutant PS-1 through a mechanism involving impairments in neurotrophin signaling and synaptic dysfunction [190] [191] [192] .
The epsilon 4 allele (e4) of the human apolipoprotein E gene (ApoE4) constitutes an important genetic risk factor for AD. were observed, suggesting impairment of axonal transport [193] .
3C2. Frontotemporal dementia (FTD)
Frontotemporal dementia (FTD) is the clinical syndrome caused by degeneration of the frontal lobe of the brain and is the second most common pre-senile dementia after AD among people under the age of 65 [194] . About 50% of FTD patients have an associated family history.
Several genes such as microtubule-associated protein tau (MAPT), progranulin (PGRN), chromatin modifying protein 2B (CHMP2B), and fused in sarcoma (FUS), have been described to be associated with FTD. Both MAPT and PGRN are pathogenic genes located on chromosome 17 associated with FTDP phenotype [195] .
FTD frequently presents with tau-containing lesions histopathologically, which result from mutations in the MAPT gene. The identification of early and progressive axonal swellings [196] and impaired Rab7 recruitment to endosomes [197] in CHMP2B increased spontaneous locomotor activity in old age [203] .
3C3. Motor neuron diseases: Amyotrophic lateral sclerosis (ALS)
Amyotrophic lateral sclerosis (ALS) is a fatal and progressive neurodegenerative disease with the selective death of motor neurons in the brain, spinal cord and brainstem as a main pathological feature which leads to muscle weakness and paralysis [204] . ALS leads specifically to muscle weakness and atrophy of limb and respiratory muscles. The molecular basis of this disease is still poorly understood and several hypotheses for its etiology is under debate [205] . Axonal transport derangement is advocated as the early molecular event and a key event of pathogenic mechanisms leading to neurodegeneration in ALS. [210] , and the reduction in the levels of KAP3 has been linked to increased survival in ALS patients [211] , While an early upregulation of the kinesin superfamily motor protein KIF1A was detected in spinal motor neurons in SOD mutant mice [212] . Retrograde transport is also disrupted in ALS mice [213] . The decreased retrograde transport was described in G93A SOD1 mice at an early stage of disease, coincident with neuromuscular junction degeneration and muscle weakness [140, 214, 215] .
Reduction of retrograde transport in ALS mice has been attributed to the mislocalization and disruption of dynein function [214] .
Mutations in the p150 subunit of dynactin is involved in ALS [154, [216] [217] [218] [219] and a dynein mutation which attenuates motor neuron degeneration in SOD1(G93A) mice has also been described [220, 221] . Mutations in dyneindynactin retrograde system protein genes has been demonstrated to be linked to neuronal degenerations in ALS mouse model [222, 223] and Drosophila melanogaster [224] , as well as distal spinal and bulbar muscular atrophy (dSBMA) [225] . Studies using autopsy material and spinal cord tissue from ALS animal models suggest that damage to the axonal cytoskeleton due to alterations of neurofilament [226] and axonal Charcot-Marie-Tooth type 2 disease (CMT2) [249] . An autosomal dominant mutation in DYNC1H1 was identified in a family with CMT2 which was also proved to cause severe intellectual disability with neuronal migration defects [250] . Mutations in the 27-kDa small heat-shock protein gene (HSPB1) cause axonal
CMT or distal hereditary motor neuropathy (distal HMN). Expression of mutant HSPB1
decreased acetylated α-tubulin abundance induced severe axonal transport deficits [251] .
Mutations in GDAP1 (ganglioside-induced differentiation-associated protein-1), which alter the interaction between mitochondria and the microtubule cytoskeleton and affect mitochondrial axonal transport and movement [252, 253] , are described as the cause of the inherited human neuropathy CMT [254, 255] disease: autosomal recessive demyelinating CMT4A [256] , autosomal recessive axonal CMT2K or dominant axonal CMT2K. Defects in axonal transport due to a mutation in the motor protein KIF1Bβ, has been described to be responsible for axonopathy in the CMT type 2A [130] .
Mitofusins (Mfn1 and Mfn2) are outer mitochondrial membrane proteins involved in regulating mitochondrial dynamics. Mutations in MFN2 alone cause CMT type 2A for the reason that Mfn2 is a key component of the linker/adaptor complex between mitochondria and kinesin/microtubules, the deficit of which produce a severe mitochondrial transport disorder in dorsal root ganglion neurons [257] .
Other motor neuron diseases Dysfunction of dynactin-mediated transport is also documented to lead human motor neuron disease [219] . Mutations in anterograde axonal transport proteins, including KIF1B, lead to slow progressive motor neuronopathy [130] . These that phosphorylate kinesin 1. Phosphorylated kinesin 1 has reduced affinity for MT leading to impaired transport [260] . Disruption of axonal transport is also described in Drosophila model for HD [261] . 
Conclusion
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